Dietary neoagarotetraose extends lifespan and impedes brain aging in mice via regulation of microbiota-gut-brain axis

Tao Li,Shaoqing Yang,Xiaoyan Liu,Yanxiao Li,Zhenglong Gu,Zhengqiang Jiang
DOI: https://doi.org/10.1016/j.jare.2023.04.014
IF: 12.822
2023-04-22
Journal of Advanced Research
Abstract:Highlights • Neoagarotetraose extended the lifespan by up to 33.3% of natural aging mice. • Neoagarotetraose improved the cerebral neuronal injuries of natural aging mice. • Neoagarotetraose increased abundance of short-chain fatty acids-producing bacteria. • Neoagarotetraose regulated the glucolipid and bile acid metabolism-related metabolic pathways. • Neoagarotetraose ameliorated cognitive impairment of Alzheimer's disease mice. Introduction Dietary oligosaccharides can impact the gut microbiota and confer tremendous health benefits. Objectives The aim of this study was to determine the impact of a novel functional oligosaccharide, neoagarotetraose (NAT), on aging in mice. Methods 8-month-old C57BL/6J mice as the natural aging mice model were orally administered with NAT for 12 months. The preventive effect of NAT in Alzheimer's disease (AD) mice was further evaluated. Aging related indicators, neuropathology, gut microbiota and short-chain fatty acids (SCFAs) in cecal contents were analyzed. Results NAT treatment extended the lifespan of these mice by up to 33.3%. Furthermore, these mice showed the improved aging characteristics and decreased injuries in cerebral neurons. Dietary NAT significantly delayed DNA damage in the brain, and inhibited reduction of tight junction protein in the colon. A significant increase at gut bacterial genus level (such as Lactobacillus , Butyricimonas , and Akkermansia ) accompanied by increasing concentrations of SCFAs in cecal contents was observed after NAT treatment. Functional profiling of gut microbiota composition indicated that NAT treatment regulated the glucolipid and bile acid-related metabolic pathways. Interestingly, NAT treatment ameliorated cognitive impairment, attenuated amyloid-β (Aβ) and Tau pathology, and regulated the gut microbiota composition and SCFAs receptor-related pathway of Alzheimer's disease (AD) mice. Conclusion NAT mitigated age-associated cerebral injury in mice through gut-brain axis. The findings provide novel evidence for the effect of NAT on anti-aging, and highlight the potential application of NAT as an effective intervention against age-related diseases. Graphical abstract Download : Download high-res image (193KB) Download : Download full-size image
multidisciplinary sciences
What problem does this paper attempt to address?